India’s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).
For more coronavirus news, visit our dedicated page.
The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.
For all the latest headlines follow our Google News channel online or via the app.
Read more:
Mount Everest climbers struggle to return home amid Nepal COVID-19 travel curbs
India plans to more than triple COVID-19 vaccine shots per day in July, August
Also Read
-
India plans to more than triple COVID-19 vaccine shots per day in July, August
India could have as many as 10 million doses of COVID-19 vaccines available per day in July and August, compared with just under three million now, ... Coronavirus -
India’s COVID-19 infections pass 28 million
India reported on Tuesday its lowest daily rise in new coronavirus infections since April 8 at 127,510 cases over the past 24 hours, while deaths rose ... Coronavirus -
Indian economy showed momentum before new, severe COVID-19 wave
India’s economy expanded faster than expected last quarter before a resurgent coronavirus pandemic unleashed a new wave of challenges.Gross domestic ... Coronavirus
